Literature DB >> 34168995

Can Smoking Cause Differences in Urine Microbiome in Male Patients With Bladder Cancer? A Retrospective Study.

Wenchao Ma1,2, Wentao Zhang1, Liliang Shen1,3, Ji Liu1, Fuhang Yang1, Niraj Maskey1, Hong Wang1, Junfeng Zhang1, Yang Yan1, Xudong Yao1,2.   

Abstract

BACKGROUND: Tobacco smoking is a carcinogen for many cancers including bladder cancer. The microbiota is involved in the occurrence, development, and treatment of tumors. We explored the composition of male urinary microbiome and the correlation between tobacco smoking and microbiome in this study.
METHODS: Alpha diversity, principal component analysis (PCA) and Adonis analysis, linear discriminant analysis (LDA) coupled with effect size measurement, and PICRUSt function predictive analysis were used to compare different microbiome between smokers and non-smokers in men.
RESULTS: There were 26 qualified samples included in the study. Eleven of them are healthy controls, and the others are from men with bladder cancer. Simpson index and the result of PCA analysis between smokers and non-smokers were not different (P > 0.05) in healthy men. However, the abundance of Bacteroidaceae, Erysipelotrichales, Lachnospiraceae, Bacteroides, and so on in the urinary tract of smokers is much higher than that of non-smokers. Compared to non-smokers, the alpha diversity in smokers was elevated in patients with bladder cancer (P < 0.05). PCA analysis showed a significant difference between smokers and non-smokers (P < 0.001), indicating that tobacco smoking plays a vital role in urinary tract microbial composition.
CONCLUSION: The composition of microbiome in the urinary tract is closely related to tobacco smoking. This phenomenon is more significant in patients with bladder cancer. This indicates tobacco smoking may promote the occurrence and development of bladder cancer by changing urinary tract microbiome.
Copyright © 2021 Ma, Zhang, Shen, Liu, Yang, Maskey, Wang, Zhang, Yan and Yao.

Entities:  

Keywords:  bladder cancer; male; microbiome; smoke; urine

Year:  2021        PMID: 34168995      PMCID: PMC8217881          DOI: 10.3389/fonc.2021.677605

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  56 in total

Review 1.  Immune checkpoint inhibitors for metastatic bladder cancer.

Authors:  Francesco Massari; Vincenzo Di Nunno; Marta Cubelli; Matteo Santoni; Michelangelo Fiorentino; Rodolfo Montironi; Liang Cheng; Anto Lopez-Beltran; Nicola Battelli; Andrea Ardizzoni
Journal:  Cancer Treat Rev       Date:  2018-01-31       Impact factor: 12.111

2.  The signalling pathway for BCG-induced interleukin-6 production in human bladder cancer cells.

Authors:  Ye Zhang; Ratha Mahendran; Lai Lai Yap; Kesavan Esuvaranathan; Hoon Eng Khoo
Journal:  Biochem Pharmacol       Date:  2002-01-15       Impact factor: 5.858

Review 3.  The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks.

Authors:  Marcus G Cumberbatch; Matteo Rota; James W F Catto; Carlo La Vecchia
Journal:  Eur Urol       Date:  2015-07-03       Impact factor: 20.096

4.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

5.  Significant Role of Lifetime Cigarette Smoking in Worsening Bladder Cancer and Upper Tract Urothelial Carcinoma Prognosis: A Meta-Analysis.

Authors:  Frits H M van Osch; Sylvia H J Jochems; Frederik J van Schooten; Richard T Bryan; Maurice P Zeegers
Journal:  J Urol       Date:  2015-10-31       Impact factor: 7.450

6.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.

Authors:  Ayelet Sivan; Leticia Corrales; Nathaniel Hubert; Jason B Williams; Keston Aquino-Michaels; Zachary M Earley; Franco W Benyamin; Yuk Man Lei; Bana Jabri; Maria-Luisa Alegre; Eugene B Chang; Thomas F Gajewski
Journal:  Science       Date:  2015-11-05       Impact factor: 47.728

Review 7.  European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

Authors:  Marko Babjuk; Maximilian Burger; Eva M Compérat; Paolo Gontero; A Hugh Mostafid; Joan Palou; Bas W G van Rhijn; Morgan Rouprêt; Shahrokh F Shariat; Richard Sylvester; Richard Zigeuner; Otakar Capoun; Daniel Cohen; José Luis Dominguez Escrig; Virginia Hernández; Benoit Peyronnet; Thomas Seisen; Viktor Soukup
Journal:  Eur Urol       Date:  2019-08-20       Impact factor: 20.096

Review 8.  Smoking and Bladder Cancer: A Systematic Review of Risk and Outcomes.

Authors:  Michael Rink; Joseph J Crivelli; Shahrokh F Shariat; Felix K Chun; Edward M Messing; Mark S Soloway
Journal:  Eur Urol Focus       Date:  2015-05-19

9.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences.

Authors:  Morgan G I Langille; Jesse Zaneveld; J Gregory Caporaso; Daniel McDonald; Dan Knights; Joshua A Reyes; Jose C Clemente; Deron E Burkepile; Rebecca L Vega Thurber; Rob Knight; Robert G Beiko; Curtis Huttenhower
Journal:  Nat Biotechnol       Date:  2013-08-25       Impact factor: 54.908

Review 10.  The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?

Authors:  Felice Crocetto; Mariarosaria Boccellino; Biagio Barone; Erika Di Zazzo; Antonella Sciarra; Giovanni Galasso; Giuliana Settembre; Lucio Quagliuolo; Ciro Imbimbo; Silvia Boffo; Italo Francesco Angelillo; Marina Di Domenico
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

View more
  5 in total

Review 1.  Regulatory mechanisms and potential medical applications of HNF1A-AS1 in cancers.

Authors:  Yang Zhang; Jiang Shi; Junfang Luo; Cong Liu; Lixu Zhu
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Bladder Microbiota Are Associated with Clinical Conditions That Extend beyond the Urinary Tract.

Authors:  Jan Hrbacek; Vojtech Tlaskal; Pavel Cermak; Vitezslav Hanacek; Roman Zachoval
Journal:  Microorganisms       Date:  2022-04-22

3.  Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer.

Authors:  Chunxiao Chen; Zehai Huang; Pengcheng Huang; Kun Li; Jiarong Zeng; Yuehui Wen; Biao Li; Jie Zhao; Peng Wu
Journal:  BMC Microbiol       Date:  2022-01-04       Impact factor: 3.605

Review 4.  Bacteria for Treatment: Microbiome in Bladder Cancer.

Authors:  Kyungchan Min; Hyun Tae Kim; Eun Hye Lee; Hansoo Park; Yun-Sok Ha
Journal:  Biomedicines       Date:  2022-07-25

5.  Bladder Tissue Microbiome Composition in Patients of Bladder Cancer or Benign Prostatic Hyperplasia and Related Human Beta Defensin Levels.

Authors:  Bassel Mansour; Ádám Monyók; Márió Gajdács; Balázs Stercz; Nóra Makra; Kinga Pénzes; István Vadnay; Dóra Szabó; Eszter Ostorházi
Journal:  Biomedicines       Date:  2022-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.